Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

In connection with the release of the results for the full year and fourth quarter 2024, Oncoinvent invites to the following events: Thursday 27 February 202507.30 CETRelease of stock exchange ...